258 related articles for article (PubMed ID: 34676990)
1. Analgesic effects of medicinal plants and phytochemicals on chemotherapy-induced neuropathic pain through glial modulation.
Lee JH; Kim N; Park S; Kim SK
Pharmacol Res Perspect; 2021 Dec; 9(6):e00819. PubMed ID: 34676990
[TBL] [Abstract][Full Text] [Related]
2. A review of complementary therapies with medicinal plants for chemotherapy-induced peripheral neuropathy.
Wu BY; Liu CT; Su YL; Chen SY; Chen YH; Tsai MY
Complement Ther Med; 2019 Feb; 42():226-232. PubMed ID: 30670246
[TBL] [Abstract][Full Text] [Related]
3. Medicinal plants and their isolated phytochemicals for the management of chemotherapy-induced neuropathy: therapeutic targets and clinical perspective.
Oveissi V; Ram M; Bahramsoltani R; Ebrahimi F; Rahimi R; Naseri R; Belwal T; Devkota HP; Abbasabadi Z; Farzaei MH
Daru; 2019 Jun; 27(1):389-406. PubMed ID: 30852764
[TBL] [Abstract][Full Text] [Related]
4. The analgesic effect of orexin-A in a murine model of chemotherapy-induced neuropathic pain.
Toyama S; Shimoyama N; Shimoyama M
Neuropeptides; 2017 Feb; 61():95-100. PubMed ID: 28041630
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy.
Lee G; Kim SK
Molecules; 2016 Sep; 21(9):. PubMed ID: 27657026
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity.
Sałat K
Pharmacol Rep; 2020 Jun; 72(3):508-527. PubMed ID: 32347537
[TBL] [Abstract][Full Text] [Related]
7. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
Schloss J; Colosimo M; Vitetta L
Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain.
Blanton HL; Brelsfoard J; DeTurk N; Pruitt K; Narasimhan M; Morgan DJ; Guindon J
Drugs; 2019 Jun; 79(9):969-995. PubMed ID: 31127530
[TBL] [Abstract][Full Text] [Related]
9. Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source.
Ma J; Kavelaars A; Dougherty PM; Heijnen CJ
Cancer; 2018 Jun; 124(11):2289-2298. PubMed ID: 29461625
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a topical gabapentin gel in a cisplatin paradigm of chemotherapy-induced peripheral neuropathy.
Shahid M; Subhan F; Ahmad N; Sewell RDE
BMC Pharmacol Toxicol; 2019 Aug; 20(1):51. PubMed ID: 31462283
[TBL] [Abstract][Full Text] [Related]
11. Mitigation of sciatica injury-induced neuropathic pain through active metabolites derived from medicinal plants.
Nasir A; Afridi OK; Ullah S; Khan H; Bai Q
Pharmacol Res; 2024 Feb; 200():107076. PubMed ID: 38237646
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced peripheral neuropathy: where are we now?
Colvin LA
Pain; 2019 May; 160 Suppl 1(Suppl 1):S1-S10. PubMed ID: 31008843
[TBL] [Abstract][Full Text] [Related]
13. Analgesic Activity.
Prog Drug Res; 2016; 71():99-102. PubMed ID: 26939272
[TBL] [Abstract][Full Text] [Related]
14. Can herbal medicinal products or preparations alleviate neuropathic pain in adults? A Cochrane Review summary with commentary.
Arienti C
NeuroRehabilitation; 2021; 48(1):149-152. PubMed ID: 33386827
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Review on Ethnomedicinal, Pharmacological and Phytochemical Basis of Anticancer Medicinal Plants of Pakistan.
Akhtar MF; Saleem A; Alamgeer ; Saleem M
Curr Cancer Drug Targets; 2019; 19(2):120-151. PubMed ID: 29984657
[TBL] [Abstract][Full Text] [Related]
16. Herbal medicinal products or preparations for neuropathic pain.
Boyd A; Bleakley C; Hurley DA; Gill C; Hannon-Fletcher M; Bell P; McDonough S
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD010528. PubMed ID: 30938843
[TBL] [Abstract][Full Text] [Related]
17. An overview of ongoing clinical trials assessing pharmacological therapeutic strategies to manage chemotherapy-induced peripheral neuropathy, based on preclinical studies in rodent models.
Bouchenaki H; Danigo A; Sturtz F; Hajj R; Magy L; Demiot C
Fundam Clin Pharmacol; 2021 Jun; 35(3):506-523. PubMed ID: 33107619
[TBL] [Abstract][Full Text] [Related]
18. Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain.
Brandolini L; d'Angelo M; Antonosante A; Allegretti M; Cimini A
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31197114
[TBL] [Abstract][Full Text] [Related]
19. Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study.
Velasco R; Navarro X; Gil-Gil M; Herrando-Grabulosa M; Calls A; Bruna J
J Pain Symptom Manage; 2017 Dec; 54(6):815-825. PubMed ID: 28797868
[TBL] [Abstract][Full Text] [Related]
20. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
Hershman DL; Lacchetti C; Dworkin RH; Lavoie Smith EM; Bleeker J; Cavaletti G; Chauhan C; Gavin P; Lavino A; Lustberg MB; Paice J; Schneider B; Smith ML; Smith T; Terstriep S; Wagner-Johnston N; Bak K; Loprinzi CL;
J Clin Oncol; 2014 Jun; 32(18):1941-67. PubMed ID: 24733808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
